Dogwood Therapeutics, Inc. Common Stock

DWTXNASDAQ • USD
ThemeBiotech - Drug Development›Neuroscience & CNS
1.69 USD
↗ 0.02 (1.20%)AT CLOSE (11:59 AM EDT)
1.69
↘ 0.01 (0.30%)
POST MARKET (AS OF 04:26 PM EDT)
Post Market
AS OF 04:26 PM EDT
1.69
↘ 0.01 (0.30%)
🔴Market: CLOSED
Open?$1.67
High?$1.70
Low?$1.66
Prev. Close?$1.67
Volume?27.5K
Avg. Volume?97.4K
VWAP?$1.68
Rel. Volume?0.28x
Bid / Ask
Bid?$1.38 × 100
Ask?$1.97 × 100
Spread?$0.59
Midpoint?$1.67
Valuation & Ratios
Market Cap?56.8M
Shares Out?33.6M
Float?8.6M
Float %?25.7%
P/E Ratio?N/A
P/B Ratio?0.70
EPS?-$0.84
Dividend?0.00%
Ex-Dividend?N/A

DWTX is currently priced at $1.69. The stock presents a bearish profile across the board: technical indicators signal "Sell" and our fundamental models agree with a "Sell" rating. This is driven by a concerning Altman Z-Score in the distress zone, a weak Piotroski F-Score of 0/9, negative Return on Equity, a bearish Death Cross on the long-term moving averages and bearish long-term moving average alignment. Valuation metrics suggest DWTX is trading at a discount to its peers, earning an "Attractively Valued" rating.

Technical & fundamental data as of May 29, 2026.

News
Profile
Dogwood Therapeutics Inc is a development-stage biopharmaceutical company focused on developing new medicines to treat pain and neuropathy. The pipeline is focused on treating chronic neuropathic pain and neuropathy. The Company operates in one segment and is a pre-revenue, development-stage biopharmaceutical company focused on developing new medicines to treat pain and peripheral neuropathy associated with cancer.
Themes
Biotech - Drug Development›Neuroscience & CNS
Employees
8
Market Cap
56.8M
Industry
PHARMACEUTICAL PREPARATIONS
Website
www.virios.com
Listed
2020-12-17
Address
44 MILTON AVENUE
ALPHARETTA, GA 30009
Phone: (866) 620-8655
Technical OutlookSell
Strong SellNeutralStrong Buy
Long-Term (Tide)?▼ Bearish(-2/3)
Medium-Term (Wave)?– Neutral(0/3)
Short-Term (Ripple)?▼ Bearish(-2/3)
MA Alignment?Bearish Alignment
Full Technical Analysis →
Fundamental OutlookSell
Strong SellNeutralStrong Buy
F-Score?
3
Z-Score?
2
Momentum?
50
Short Sent.?
75
Piotroski F-Score?0/9Weak
Altman Z-Score?-0.16Distress
Confidence?39%Very Low
Full Fundamental Analysis →
Short InterestLow
Short % of Float?1.27%Low
Short Interest?108.4K
Days to Cover?1.0
Free Float8.6M
Avg Daily Volume111.6K
Settlement Date2026-05-15
Financial Health
Current Ratio?5.86Strong
Quick Ratio?5.86Strong
Cash Ratio?5.17Strong
Debt/Equity?0.00Low
ValuationATTRACTIVELY VALUEDvs 1 peers + S&P 500
Score
100/100
P/E?
N/A▾
P/B?
Peers
100
S&P
97
0.70CHEAP▾
P/S?
N/A▾
P/FCF?
N/A▾
EV/EBITDA?
S&P
97
-1.5CHEAP▾
EV/Sales?
N/A▾
Returns & Efficiency
ROE?
S&P
5
-35.1%WEAK▾
ROA?
S&P
3
-29.7%WEAK▾
Cash Flow & Enterprise
FCF?N/A
Enterprise Value?$43.6M
Fundamentals ratios updated end of day
MarketsMoversWatchlist